<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - PTC Therapeutics, Inc. (PTCT)</title>
    <description>Latest news, press releases, and SEC filings for PTC Therapeutics, Inc. (PTCT)</description>
    <link>https://caymanjournal.com/stock/PTCT</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Mon, 27 Apr 2026 21:45:10 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/PTCT/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>DEF 14A — PTC THERAPEUTICS, INC.</title>
      <description># 📜 What This Document Is 🗓️
This is a Proxy Statement (DEF 14A), which is like a comprehensive instruction manual and invitation to an annual shareholder meeting. Instead of just reporting numbers, this document is designed to inform you—the shareholder—about how the company is run, who is leadin</description>
      <link>https://caymanjournal.com/stock/PTCT/sec-filing/0001104659-26-045528</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/PTCT/sec-filing/0001104659-26-045528</guid>
      <pubDate>Mon, 20 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>